Medicus Pharma Shares Are Trading Higher After the Company Its INAD File No.013880 Was Used as Part of a Major Species Designation From the FDA.

BenzingaDec 12 21:27

Medicus Pharma up 9% in Pre-market Trading as FDA Approves Anti-cancer Patch for Horses

MT NewswiresDec 12 21:18

Medicus Pharma Eyes Veterinary Market With FDA Designation

TipRanksDec 12 21:07

Medicus Pharma Says INAD File No.013880 Received Minor Use In Major Species Designation From FDA For Its Dissolvable D-MNA To Treat External Squamous Cell Carcinoma In Horses

BenzingaDec 12 20:47

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation From the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

newsfileDec 12 20:30

Medicus Pharma Eyes Pivotal Trial for Novel Skin Cancer Therapy as Phase 2 Enrollment Progresses | TSX-V:MDCX, NASDAQ:MDCX

Proactive InvestorsDec 3 03:44